Table 2.
Serum hormone content in the entire cohort.
| Eutrophic | Obesity | Two-way ANOVA | |||||
|---|---|---|---|---|---|---|---|
| pg/ml | Female | Male | Female | Male | Sex | Obes. | SxO |
| Insulin | 1,678 ± 67.54 | 1,659 ± 46.86 | 2,772 ± 131 | 2,704 ± 133.8 | 0.659 | <0.0001 | 0.806 |
| Leptin | 9,610 ± 1021 | 4,519 ± 308.1 | 34,623 ± 4,638 | 20,904 ± 2,834 | <0.0001 | <0.0001 | 0.416 |
| Amylin | 154.1 ± 10.71 | 179.6 ± 13.99 | 218.2 ± 16.94 | 230.4 ± 14.54 | 0.186 | 0.0001 | 0.636 |
| C-peptide | 438.7 ± 49.88 | 502.7 ± 44.57 | 1,224 ± 113.3 | 1,049 ± 112.7 | 0.505 | <0.0001 | 0.153 |
| Ghrelin | 60.87 ± 10.84 | 53.34 ± 11.05 | 77 ± 12 | 69.84 ± 10.06 | 0.494 | 0.0407 | 0.623 |
| GIP | 49.23 ± 3.58 | 66.61 ± 7.85 | 54.45 ± 3.27 | 61.2 ± 3.89 | 0.012 | 0.457 | 0.358 |
| GLP-1 | 76.05 ± 3.04 | 76.05 ± 2.69 | 94.08 ± 4.57 | 103.2 ± 2.73 | 0.145 | <0.0001 | 0.175 |
| Glucagon | 142.6 ± 3.39 | 145.3 ± 2.36 | 155.8 ± 6.16 | 157.1 ± 4.89 | 0.474 | 0.0022 | 0.839 |
| PP | 69.28 ± 5.22 | 75.64 ± 6.61 | 79.18 ± 9.40 | 81.16 ± 5.49 | 0.227 | 0.166 | 0.991 |
| PYY | 325.2 ± 6.49 | 324.7 ± 6.98 | 329.7 ± 5.42 | 332.7 ± 5.45 | 0.854 | 0.252 | 0.756 |
Eutrophic female, n = 24; Eutrophic male, n = 25; Obesity female, n = 22; Obesity male, n = 21. Obes., Obesity factor; SxO, Interaction between factors (sex and obesity); GIP, gastric inhibitory polypeptide; GLP-1, glucagon-like peptide-1; PP, pancreatic polypeptide; PYY, peptide tyrosine tyrosine. Data are presented as mean ± sem. Significance between groups was tested using two-way ANOVA test. Significant difference p-values appear in bold.